In conclusion, we found that EC treatment increases ER stress by activating the PERK–eIF2α–ATF4 signaling pathway, thereby promoting iron-related death in lung cancer cells and alleviating lung cancer progression (Fig 7). The gene discussed is EIF2AK3; the disease is lung carcinoma.